GlassScriptPhysician profile
Janel Pietryga
NPI 1518498625
$17,013.45
in general payments reported to CMS, 2019-2025
7 companies · $1,951 in 2025
The $1,951 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,599 · 2023: $3,492 · 2024: $8,971 · 2025: $1,951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,899 · Food and Beverage: $4,423 · Travel and Lodging: $2,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,899.22 |
| Food and Beverage | $4,423.10 |
| Travel and Lodging | $2,091.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $10,118.93 | 2022-2025 | Vistaseal |
| Depuy Synthes Sales INC. | $2,429.99 | 2022-2025 | Na, Lcp, Hammerlock |
| Stryker Corporation | $1,953.37 | 2022-2024 | T2, Pelvis II, Gamma |
| Goode Surgical INC | $1,786.48 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $530.66 | 2022-2025 | Tapestry |
| Osteocentric Technologies, INC. | $148.02 | 2023-2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Zimvie INC. | $46.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janel Pietryga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.